142 related articles for article (PubMed ID: 1695305)
21. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
Fitscha P; Meisner W; Hitzenberger G
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
[TBL] [Abstract][Full Text] [Related]
22. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Sievert A; Aurell M; Hansson L
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S102-4. PubMed ID: 2455104
[TBL] [Abstract][Full Text] [Related]
23. Effects of isradipine on hypertension and renal hemodynamics.
Siamopoulos KC; Elisaf M; Dardamanis M; Sferopoulos G; Pappas M
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S87-9. PubMed ID: 1376846
[TBL] [Abstract][Full Text] [Related]
24. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
Burger KJ; Anlauf M
Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
[TBL] [Abstract][Full Text] [Related]
25. Isradipine, a new calcium antagonist: effects on maternal and fetal hemodynamics.
Lunell NO; Garoff L; Grunewald C; Nisell H; Nylund L; Sarby B; Thornström S
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S37-40. PubMed ID: 1720484
[TBL] [Abstract][Full Text] [Related]
26. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society.
Lüscher TF; Waeber B
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S1-3. PubMed ID: 1720476
[TBL] [Abstract][Full Text] [Related]
27. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
Edouard A; Dartayet B; Ruegg C; Samii K
Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
[TBL] [Abstract][Full Text] [Related]
28. Long-term (2-year) isradipine data in the treatment of mild-to-moderate hypertension.
D'Hont G; Meurant JP; Clement DL; Rorive G; Hermans L; De Keyser P; Westelinck KJ
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S46-8. PubMed ID: 1376834
[TBL] [Abstract][Full Text] [Related]
29. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
[TBL] [Abstract][Full Text] [Related]
30. [Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine].
Mauser M; Voelker W; Karsch KR
Z Kardiol; 1988 Jun; 77(6):373-7. PubMed ID: 2975095
[TBL] [Abstract][Full Text] [Related]
31. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
[TBL] [Abstract][Full Text] [Related]
32. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
Nelson EB; Pool JL; Taylor AA
Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
[TBL] [Abstract][Full Text] [Related]
34. Additive effect of isradipine in combination with captopril in hypertensive patients.
Eggertsen R; Svensson A; Dahlöf B; Hansson L
Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic response, safety, and efficacy of isradipine in the treatment of essential hypertension.
Dahlöf B
Am J Med; 1989 Apr; 86(4A):19-26. PubMed ID: 2523651
[TBL] [Abstract][Full Text] [Related]
36. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
Welzel D; Burger KJ
Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
Am J Med; 1989 Apr; 86(4A):110-4. PubMed ID: 2523644
[TBL] [Abstract][Full Text] [Related]
38. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646
[TBL] [Abstract][Full Text] [Related]
39. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
[TBL] [Abstract][Full Text] [Related]
40. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.
Simonsen K; Sundstedt CD
Am J Med; 1989 Apr; 86(4A):91-3. PubMed ID: 2523663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
